Posted by Hugh on September 6, 2015, at 13:10:52
"Most clinicians in this field know that it is very challenging to treat patients with depression or anxiety because the drugs we have only initially work for about 50% of patients, and success goes down with each successive drug failure," Anthony Altar, PhD, senior vice president, Assurex Health, maker of the test that sponsored the study, told Medscape Medical News.
"So we are focusing on patients who do not have a good response to their current drug, and we are finding that patients do much better when their healthcare provider is aided by the GeneSight test results," he said.
To obtain test results, physicians take a cheek swab from their patient and send it to Assurex Health, where it is analyzed for DNA variations.
Results of the analysis are detailed in a report, and psychotropic medications are placed into one of three categories: use as directed; use with caution; or use with increased caution and with more frequent monitoring.
Complete article:
poster:Hugh
thread:1082150
URL: http://www.dr-bob.org/babble/20150901/msgs/1082150.html